美国Marina Biotech
基于RNA干扰（RNAi）治疗产品的开发和商品化为重点。我们正在建设的多个尖端药物发现和开发平台的基础上，没有一个单一的RNAi技术或交付方法可以广泛应用到所有人类疾病的治疗的前提下。

Marina Biotech is a biotechnology company focused on the development and commercialization of therapeutic products based on RNA interference (RNAi). We are building multiple cutting-edge drug discovery and development platforms based on the premise that no single RNAi technology or delivery approach can be broadly applied to the treatment of all human diseases.